Skip to main content
  • Apply
  • Admissions
  • Donate
  • Student Noticeboard
  • Give a Day to LUMS
  • News
  • Events
  • Contact

Lums Logo

learning without borders

portal

Home
  • Explore LUMS

    • About LUMS
    • Office of the Vice Chancellor
    • Office of the Provost
    • Offices at LUMS
    • Rankings and Accreditation
    • News & Events
    • Resources
    • University Advisory Board
    • History
    • Contact Us
  • Admissions

    • Programme Finder
    • Admissions Home
    • Undergraduate Programmes
    • Graduate Programmes
    • Financial Aid and Scholarships
    • National Outreach Programme
    • International Students
    • Why LUMS
    • Apply Now
  • Academics

    • Suleman Dawood School of Business
    • Mushtaq Ahmad Gurmani School of Humanities and Social Sciences
    • Syed Babar Ali School of Science and Engineering
    • Shaikh Ahmad Hassan School of Law
    • Syed Ahsan Ali and Syed Maratib Ali School of Education
    • Executive Education
    • Continuing Education
    • Learning Institute
  • Faculty & Research

    • Faculty Profiles
    • Research and Innovation
    • Centres
  • Alumni

    • Alumni Relations
    • Alumni Benefits
    • VC Alumni Achievement Awards
    • Alumni Annual
  • Donors

    • Giving to LUMS
    • Give a day to LUMS Campaign
    • LUMS Supporters
lums employee profile image
Dr. Amir Faisal
Associate Professor
Syed Babar Ali School of Science and Engineering
amir.faisal@lums.edu.pk
  • Profile
  • Conferences, Publications and Journal Articles

Dr. Amir Faisal received his PhD in Cell Biology from Friedrich Miescher Institute for Biomedical Research/University of Basel, Switzerland in 2004. During his PhD he identified novel roles for Shc protein, an important adaptor downstream of tyrosine kinases, in insulin signalling and cytoskeletal reorganization. He received his first postdoctoral training (2004-2008) in Protein Phosphorylation Laboratory at London Research Institute where he discovered that another adaptor protein, MyD88, couples Protein Kinase C epsilon to Toll like receptors during innate immunity. From 2008 to 2014, he worked at Cancer Therapeutics Unit of Institute of Cancer Research in Sutton first as postdoctoral fellow and later as senior scientist. He played an important role in progression of several drug discovery projects, one of which resulted in discovery of a pre-clinical development candidate that will undergo phase I clinical trials in 2016. After joining LUMS in August 2014, he has been establishing a cancer therapeutics lab at SBASSE.\

URL: http://biolabs.lums.edu.pk/cancer

Title Publication Author Year
Selenium-containing Peptides and their Biological Applications Current Medicinal Chemistry 2022
Synthesis and Characterization of Griseofulvin Derivatives as Microtubule-Stabilizing Agents ChemistrySelect 2022
Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors Frontiers in Chemistry 2022
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors Journal of Natural Products 2022
Synthesis and Evaluation of Novel Carboxamides Capable of Causing Centrosome Declustering and Apoptosis in Breast Cancer Cells ChemistrySelect 2022
Reduction-Sensitive Dextran-Paclitaxel Polymer-Drug Conjugate: Synthesis, Self-Assembly into Nanoparticles, and in Vitro Anticancer Efficacy Bioconjugate Chemistry 2021
Polycomb Requires Chaperonin Containing TCP-1 Subunit 7 for Maintaining Gene Silencing in Drosophila Frontiers in Cell and Developmental Biology 2021
CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells British Journal of Cancer 2021
A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal Cancer Frontiers in Oncology 2021
Synthesis of diosgenin conjugated gold nanoparticles using algal extract of Dictyosphaerium sp. and in-vitro application of their antiproliferative activities Materials Today Communications 2021
Glyceryl Monostearate Based Solid Lipid Nanoparticles for Controlled Delivery of Docetaxel Current Drug Delivery 2021
Natural and Semisynthetic Chalcones as Dual FLT3 and Microtubule Polymerization Inhibitors Journal of Natural Products 2020
Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil International Journal of Pharmaceutics 2020
Transcriptomic analysis reveals differential gene expression, alternative splicing, and novel exons during mouse trophoblast stem cell differentiation Stem Cell Research and Therapy 2020
A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)mediated multidrug resistance PLoS ONE 2020
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736 Blood Advances 2020
A facile and versatile route to functional poly(propylene) surfaces via UV-curable coatings Reactive and Functional Polymers 2019
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species European Journal of Pharmaceutical Sciences 2019
Effect of Extraction Methodologies on Antioxidant Potential and Synergistic Anticancer Behavior of Leaf Extract of Polygonum amplexicaule Against HCT-116 Cells Iranian Journal of Science and Technology, Transaction A: Science 2019
Synthesis and evaluation of novel ??-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance Bioorganic Chemistry 2019
Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells Cell Cycle 2019
Hydrothermal synthesis of carbon nanodots from bovine gelatin and PHM3 microalgae strain for anticancer and bioimaging applications Nanoscale Advances 2019
High proliferation rate and a compromised spindle assembly checkpoint confers sensitivity to the MPS1 inhibitor BOS172722 in triple-negative breast cancers Molecular Cancer Therapeutics 2019
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance Scientific Reports 2018
ATLANTIS - Attractor Landscape Analysis Toolbox for Cell Fate Discovery and Reprogramming Scientific Reports 2018

Related links | Lums Faculty Member Profile

  • Research and Innovation
  • Centres at LUMS

Related News

  • LUMS Vice Chancellor gives Keynote Address on Evolution of Education in Pakistan

  • LUMS hosts Graduate and Undergraduate Open House for Prospective Applicants

  • Group Head, British American Tobacco, Gives Talk at LUMS

footer logo

  • parent one

    • Student affairs
    • Academic calendar
    • library
    • pay online
  • Parent Two

    • Financial Statements
    • phone directory
    • emergency services
    • campus mail
  • parent three

    • contact us
    • Directions to LUMS
    • Careers
    • Privacy Policy
  • parent four

    • Facebook
    • Facebook Group
    • Instagram
    • Youtube
lets-talk

DHA, Lahore Cantt. 54792, 
Lahore, Pakistan

Phone: +92 42 3560 8000

Subscribe
 

Search for publications, programme, event, people and much more...

X

logo

 

We will get back to you shortly.
logo

 

We will get back to you shortly.
logo

 

We will get back to you shortly.

2022 © Lahore University of Management Sciences. All Rights Reserved.